Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
146.47
-0.92 (-0.62%)
At close: Dec 20, 2024, 4:00 PM
147.65
+1.18 (0.81%)
After-hours: Dec 20, 2024, 6:13 PM EST
Biogen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 9,608 | 9,836 | 10,173 | 10,982 | 12,670 | 13,670 | Upgrade
|
| Other Revenue | - | - | - | - | 774.6 | 707.7 | Upgrade
|
| Revenue | 9,608 | 9,836 | 10,173 | 10,982 | 13,445 | 14,378 | Upgrade
|
| Revenue Growth (YoY) | -3.86% | -3.32% | -7.36% | -18.32% | -6.49% | 6.88% | Upgrade
|
| Cost of Revenue | 2,345 | 2,533 | 2,278 | 2,110 | 1,805 | 1,955 | Upgrade
|
| Gross Profit | 7,262 | 7,302 | 7,895 | 8,872 | 11,639 | 12,423 | Upgrade
|
| Selling, General & Admin | 2,316 | 2,502 | 2,409 | 2,680 | 2,516 | 2,359 | Upgrade
|
| Research & Development | 2,067 | 2,458 | 2,229 | 2,497 | 3,985 | 2,273 | Upgrade
|
| Other Operating Expenses | 251.6 | 218.8 | -7.4 | 7.2 | 232.9 | 241.6 | Upgrade
|
| Operating Expenses | 5,007 | 5,420 | 4,877 | 5,436 | 6,988 | 5,147 | Upgrade
|
| Operating Income | 2,256 | 1,882 | 3,019 | 3,436 | 4,651 | 7,275 | Upgrade
|
| Interest Expense | -261.8 | -246.9 | -246.6 | -250.4 | -213.1 | -187.4 | Upgrade
|
| Interest & Investment Income | 72.9 | 276.5 | 89.3 | 11 | 42 | 120 | Upgrade
|
| Earnings From Equity Investments | - | - | 2.6 | 34.9 | 5.3 | -79.4 | Upgrade
|
| Currency Exchange Gain (Loss) | -45.2 | -50.4 | -35.5 | -22.4 | -10.7 | -7 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.3 | -1.7 | -7.1 | -4 | 7.8 | -44.4 | Upgrade
|
| EBT Excluding Unusual Items | 2,020 | 1,860 | 2,821 | 3,205 | 4,482 | 7,077 | Upgrade
|
| Merger & Restructuring Charges | -155.2 | -271.7 | -131.1 | - | - | -27.7 | Upgrade
|
| Gain (Loss) on Sale of Investments | -23.8 | -291.2 | 1,228 | -824.9 | 685.7 | 204.7 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 503.7 | - | 92.5 | -55.3 | Upgrade
|
| Asset Writedown | - | - | -119.6 | -629.3 | -209.7 | -215.9 | Upgrade
|
| Legal Settlements | - | - | -917 | - | - | - | Upgrade
|
| Other Unusual Items | 64.8 | - | 209.1 | 47.5 | 76.9 | 63.7 | Upgrade
|
| Pretax Income | 1,906 | 1,297 | 3,594 | 1,780 | 5,053 | 7,047 | Upgrade
|
| Income Tax Expense | 291.7 | 135.3 | 632.8 | 52.5 | 992.3 | 1,158 | Upgrade
|
| Earnings From Continuing Operations | 1,614 | 1,162 | 2,962 | 1,728 | 4,061 | 5,889 | Upgrade
|
| Minority Interest in Earnings | 0.8 | -0.4 | 85.3 | -171.5 | -59.9 | - | Upgrade
|
| Net Income | 1,615 | 1,161 | 3,047 | 1,556 | 4,001 | 5,889 | Upgrade
|
| Net Income to Common | 1,615 | 1,161 | 3,047 | 1,556 | 4,001 | 5,889 | Upgrade
|
| Net Income Growth | 10.49% | -61.89% | 95.80% | -61.10% | -32.06% | 32.90% | Upgrade
|
| Shares Outstanding (Basic) | 145 | 145 | 145 | 149 | 161 | 187 | Upgrade
|
| Shares Outstanding (Diluted) | 146 | 146 | 146 | 150 | 161 | 187 | Upgrade
|
| Shares Change (YoY) | 0.34% | -0.27% | -2.41% | -7.25% | -13.93% | -8.72% | Upgrade
|
| EPS (Basic) | 11.12 | 8.02 | 20.97 | 10.44 | 24.86 | 31.47 | Upgrade
|
| EPS (Diluted) | 11.06 | 7.97 | 20.87 | 10.40 | 24.80 | 31.42 | Upgrade
|
| EPS Growth | 10.05% | -61.81% | 100.67% | -58.06% | -21.07% | 45.60% | Upgrade
|
| Free Cash Flow | 1,948 | 1,270 | 1,144 | 3,382 | 3,805 | 6,564 | Upgrade
|
| Free Cash Flow Per Share | 13.34 | 8.72 | 7.84 | 22.61 | 23.59 | 35.03 | Upgrade
|
| Gross Margin | 75.59% | 74.24% | 77.61% | 80.79% | 86.57% | 86.40% | Upgrade
|
| Operating Margin | 23.48% | 19.14% | 29.67% | 31.29% | 34.59% | 50.60% | Upgrade
|
| Profit Margin | 16.81% | 11.81% | 29.95% | 14.17% | 29.76% | 40.96% | Upgrade
|
| Free Cash Flow Margin | 20.27% | 12.91% | 11.25% | 30.79% | 28.30% | 45.65% | Upgrade
|
| EBITDA | 2,885 | 2,377 | 3,537 | 3,923 | 5,108 | 7,740 | Upgrade
|
| EBITDA Margin | 30.03% | 24.17% | 34.77% | 35.73% | 38.00% | 53.83% | Upgrade
|
| D&A For EBITDA | 629.3 | 494.8 | 518.4 | 487.7 | 457.2 | 464.7 | Upgrade
|
| EBIT | 2,256 | 1,882 | 3,019 | 3,436 | 4,651 | 7,275 | Upgrade
|
| EBIT Margin | 23.48% | 19.14% | 29.67% | 31.29% | 34.59% | 50.60% | Upgrade
|
| Effective Tax Rate | 15.30% | 10.43% | 17.61% | 2.95% | 19.64% | 16.43% | Upgrade
|
| Revenue as Reported | 9,608 | 9,836 | 10,173 | 10,982 | 13,445 | 14,378 | Upgrade
|
| Advertising Expenses | - | 71.4 | 54.1 | 98.7 | 111.8 | 79.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.